Michael Graves
Chief Executive Officer chez EAGLE PHARMACEUTICALS, INC.
Fortune : 54 286 $ au 31/03/2024
Profil
Michael Graves is currently the Executive Chairman & Chief Executive Officer at Eagle Pharmaceuticals, Inc., the Executive Chairman at Nanocopoeia, Inc., and the Director at RiboCor, Inc. Previously, he served as the President & Chief Executive Officer at Paddock Laboratories, Inc., the President-Generic Products Division at Endo Generics Holdings, Inc., and the President-Generic Products Division at Par Pharmaceutical, Inc. He obtained his undergraduate degree from the State University of New York at Buffalo.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
12/02/2024 | 10 360 ( 0,08% ) | 54 286 $ | 31/03/2024 |
Postes actifs de Michael Graves
Sociétés | Poste | Début |
---|---|---|
EAGLE PHARMACEUTICALS, INC. | Chief Executive Officer | 27/11/2023 |
Ribocor, Inc.
Ribocor, Inc. Pharmaceuticals: MajorHealth Technology Ribocor, Inc. developes nutritional, medical and pharmaceutical products. The company is headquartered in Minneapolis, MN. | Director/Board Member | 01/01/2012 |
Nanocopoeia, Inc.
Nanocopoeia, Inc. Pharmaceuticals: MajorHealth Technology Nanocopoeia, Inc. operates as a specialty pharmaceutical company. It improves the performance of existing drugs and create bioequivalent formulations through the use of their ElectroNanospray™. The company was founded by Robert Hoerr and is headquartered in St. Paul, MN. | Chairman | 01/12/2011 |
Anciens postes connus de Michael Graves
Sociétés | Poste | Fin |
---|---|---|
Paddock Laboratories, Inc.
Paddock Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Paddock Laboratories, Inc. manufactures bioequivalent generic pharmaceuticals and OTC products. Paddock's product line includes drugs for suppositories, diabetes treatments, dermatology, enemas, and injectables, as well as compounding bases and charcoal products. Paddock Laboratories was founded in 1977 by Bruce Paddock and is headquartered in Minneapolis, MN. | Chief Executive Officer | 01/07/2011 |
PAR PHARMACEUTICAL COMPANIES, INC. | Corporate Officer/Principal | 15/11/2006 |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Corporate Officer/Principal | 01/01/2006 |
Formation de Michael Graves
State University of New York at Buffalo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EAGLE PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Paddock Laboratories, Inc.
Paddock Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Paddock Laboratories, Inc. manufactures bioequivalent generic pharmaceuticals and OTC products. Paddock's product line includes drugs for suppositories, diabetes treatments, dermatology, enemas, and injectables, as well as compounding bases and charcoal products. Paddock Laboratories was founded in 1977 by Bruce Paddock and is headquartered in Minneapolis, MN. | Health Technology |
Ribocor, Inc.
Ribocor, Inc. Pharmaceuticals: MajorHealth Technology Ribocor, Inc. developes nutritional, medical and pharmaceutical products. The company is headquartered in Minneapolis, MN. | Health Technology |
Nanocopoeia, Inc.
Nanocopoeia, Inc. Pharmaceuticals: MajorHealth Technology Nanocopoeia, Inc. operates as a specialty pharmaceutical company. It improves the performance of existing drugs and create bioequivalent formulations through the use of their ElectroNanospray™. The company was founded by Robert Hoerr and is headquartered in St. Paul, MN. | Health Technology |